Chemoinformaics analysis of Myrcenone
Molecular Weight | 150.221 | nRot | 4 |
Heavy Atom Molecular Weight | 136.109 | nRig | 4 |
Exact Molecular Weight | 150.104 | nRing | 0 |
Solubility: LogS | -2.411 | nHRing | 0 |
Solubility: LogP | 2.626 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.446 |
Synth | 3.355 |
Natural Product Likeliness | 1.922 |
NR-PPAR-gamma | 0.04 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.014 |
HIA | 0.004 |
CACO-2 | -4.292 |
MDCK | 0.0000278 |
BBB | 0.368 |
PPB | 0.864634 |
VDSS | 2.378 |
FU | 0.0789133 |
CYP1A2-inh | 0.57 |
CYP1A2-sub | 0.865 |
CYP2c19-inh | 0.295 |
CYP2c19-sub | 0.892 |
CYP2c9-inh | 0.143 |
CYP2c9-sub | 0.524 |
CYP2d6-inh | 0.161 |
CYP2d6-sub | 0.704 |
CYP3a4-inh | 0.018 |
CYP3a4-sub | 0.434 |
CL | 7.501 |
T12 | 0.896 |
hERG | 0.006 |
Ames | 0.02 |
ROA | 0.749 |
SkinSen | 0.956 |
Carcinogencity | 0.748 |
EI | 0.986 |
Respiratory | 0.969 |
NR-Aromatase | 0.151 |
Antiviral | No |
Prediction | 0.945036 |